Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA).
Jesús HermosillaRicardo Sánchez-MartínRaquel Pérez-RoblesAntonio Salmerón-GarcíaSalvador CasaresJose CabezaLuis Cuadros-RodríguezNatalia NavasPublished in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2019)
High levels of similarity were noticed in the behavior of INF and CT-P13 when subjected to stress. When stored refrigerated at between 2 and 8 °C and prepared as normally used in the hospital pharmacy, all solutions showed physicochemical and functional stability for all the concentrations tested and all containers, at least for the 14-day test period.